Customize your JAMA Network experience by selecting one or more topics from the list below.
Schaub F, Cursiefen C, Heindl LM. Retrospective Appraisal of Split-Cornea Transplantation: An Audit of 1141 Donor Corneas. JAMA Ophthalmol. 2015;133(9):1086–1087. doi:10.1001/jamaophthalmol.2015.1684
For more than 100 years, penetrating keratoplasty (PK) with full-thickness replacement of a diseased cornea with an allograft donor tissue has been successfully performed. Especially within the last 10 years, surgical techniques have been improved to the point that selective replacement of the diseased structure of the cornea is possible.1 Diseases of the corneal endothelium (eg, Fuchs endothelial dystrophy, pseudophakic bullous keratoplasty) are the main reasons for corneal transplantations2 and can be managed by Descemet stripping automated endothelial keratoplasty or Descemet membrane endothelial keratoplasty (DMEK).1,3,4 Deep anterior lamellar keratoplasty (DALK) allows selective replacement of the anterior pathologic corneal tissue (eg, advanced keratoconus, herpetic corneal scarring).1,3,4 Approximately 80% of indications for keratoplasty can be covered by selective replacement.5 The increasing demand and declining amount of available donor tissue led surgeons to the idea of splitting donor tissue for 2 recipients. The most common strategy is combining DALK with DMEK.2-5 The first studies on split-cornea transplantation documented promising results with saving rates up to 47% of donor buttons.3 The purpose of our study is to retrospectively evaluate the practicability of split-cornea transplantation in clinical routine.
Between July 1, 2011, and December 31, 2014, 1141 donor corneas were transplanted at the Department of Ophthalmology, University of Cologne, Cologne, Germany. Lamellar corneal grafts were performed preferentially. Penetrating keratoplasty was applied only if full-thickness replacement of the cornea was required (eg, in scarring, ulcerations, surgical macroperforation during DALK).
In split-cornea transplantation, the anterior part of the donor button was used for DALK in one patient and the posterior part was used for DMEK in another patient. Depending on the availability of the patients, either DALK or DMEK was performed first. Remaining donor lenticules were grafted within 1 week. They were stored in culture medium (Biochrom) containing penicillin/streptomycin, amphotericin B, and fetal calf serum at 31°C ± 1°C. Microbiological tests were performed before and after surgery.
Main outcome measures included the technique of surgical intervention (intended and performed) as well as the split use of donor tissue.
This retrospective, nonrandomized, clinical study conformed with the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients before surgery. The study was approved prospectively by the University of Cologne Institutional Review Board.
A total of 1141 donor corneas were used for 1237 transplantations (714 DMEKs, 316 PKs, 100 DALKs, 74 Descemet stripping automated endothelial keratoplasties, and 33 others [7 Boston keratoprostheses and 26 tectonic corneoscleral patches]) in 951 patients (475 women, 476 men; mean [SD] age, 64.3 [17.4] years). Both DALK and DMEK were combined in 72 cases (75.0%), DMEK and tectonic corneoscleral patches were combined in 13 cases (13.5%), mini-PK (eccentric PKs, diameter ≤5 mm) and small DMEKs were combined in 5 cases (5.2%), Descemet stripping automated endothelial keratoplasty and tectonic corneoscleral patches were combined in 5 cases (5.2%), and Boston keratoprosthesis was combined with DMEK in 1 case (1.1%). Split-cornea transplantation was intended but not possible in 5 cases owing to conversion of DALK to PK (2 cases) or unexpected intraoperative events during DMEK surgery (3 cases), including complicated unfolding of the donor membrane. A total of 15.1% of corneal grafts could be performed as split-cornea transplantation, and a total of 96 donor buttons (7.8% [95% CI, 6.2%-9.4%]) could be saved.
Our data show that indications and referrals for DMEK exceed those for DALK by far (714 vs 100, respectively). Only 15.1% of corneal grafts could be performed as split-cornea transplantation, resulting in 96 donor corneas being saved (7.8%). This asymmetric distribution suggests the need for scheduling DMEK and DALK recipients. Novel techniques with the potential to increase the availability of donor tissue, eg, using hemi-DMEKs (splitting 1 endothelial graft into 2 half-moon–shaped grafts),3,6 should be considered.
Corresponding Author: Friederike Schaub, MD, Department of Ophthalmology, University of Cologne, Kerpener Strasse 62, 50924 Cologne, Germany (firstname.lastname@example.org).
Published Online: June 11, 2015. doi:10.1001/jamaophthalmol.2015.1684.
Author Contributions: Dr Schaub had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Cursiefen, Heindl.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Schaub, Heindl.
Critical revision of the manuscript for important intellectual content: Cursiefen, Heindl.
Statistical analysis: Schaub, Heindl.
Obtained funding: Cursiefen, Heindl.
Administrative, technical, or material support: Cursiefen, Heindl.
Study supervision: Cursiefen.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Funding/Support: This work was supported by grant Forschergruppe 2240 from the German Research Foundation and by grant Biomedicine 1302 from European Cooperation in Science and Technology.
Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Create a personal account or sign in to: